Plasma Resilience: Europe's Lifeline
Human plasma, a protein-rich liquid making up 55% of our blood, is crucial for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
The plasma supply chain in Europe is vulnerable, relying on the generosity of donors, with over 12 million people donating plasma annually, governed by EU and international safety standards.
- International Quality Plasma Program (IQPP)
- Plasma Protein Therapeutics Association (PPTA)
Despite this, nearly 40% of plasma used in European medicines is imported from the United States, highlighting the need to strengthen the plasma supply chain.
Therapies made from plasma exist only thanks to the generosity of real people.
Author's summary: Europe's plasma supply chain is vulnerable and needs strengthening.
More News
- How South Africa’s transformer manufacturing industry can fill a gaping local and national infrastructure gap
- Diane Keaton cause of death revealed
- Kada Scott: Arrest made in disappearance of 23-year-old Philadelphia woman as search continues
- Mount Pleasant residents urge town council for speed humps after near-miss incident
- Land spat highlights tension between traditional and formal law
- Indianapolis airport won't play Kristi Noem's video. Legal experts say it breaks the law
- Witches Night Out fundraiser to support cancer patients at Wellness House
- Domestic violence leads murders; Las Vegas honors victims in ceremony
- Who won fashion month SS26 on social media?
- How RIAs can decide their optimal client household count